glp-1 drugs shortage How Markets Solved the The Multi-Sector Impacts of GLP-1RA

Its a prescription drug with many uses, including treating type 2 diabetes in certain adults.

Learn what patients and prescribers should know about lean mass, protein, and exercise.

By 2030, the global prevalence of obesity is expected to reach one billion

Purpose of the Review Glucagon-like peptide 1 (GLP-1) receptor agonists (RA) have transformed obesity and type 2 diabetes (T2D) management

Real-world data show early discontinuation of GLP-1 therapy is linked to higher risks of coronary artery disease and heart failure.

Insurers find themselves in the position of needing to say "yes" or "no" to GLP-1 drugs as more people seek them for weight loss